ProHealth fibromyalgia Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Lady Gaga Documentary Reveals the Severity of Her Fibromyalgia Pain

VIDEO: Fibromyalgia is Real - A Video for Nonbelievers

Why Lady Gaga having fibromyalgia is both a blessing and curse for the fibromyalgia community

An Overlooked Issue in Fibromyalgia? Study Highlights Problems Standing (Orthostatic Intolerance)

Is the Fibro-fog in Fibromyalgia a Prelude to Dementia?

Glial Cell Inhibitors: The Next Sleep Drugs for Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS)?

How Myofascial Release Got Me Back On My Feet Again

Born this Way – Me & Lady Gaga

Pain and Prejudice: Surviving Fibromyalgianess

Unravelling the Mysteries of ME/CFS and Fibromyalgia: Meet the Man Behind the Book

 
Print Page
Email Article

NIH Invests $3.4M in Michigan Team’s Fibromyalgia Research – Recruitment Begins Feb 2011

  [ 12 votes ]   [ 2 Comments ]
www.ProHealth.com • November 12, 2010


A Wayne State University researcher will lead an investigation by experts at WSU and two other medical centers in Michigan to determine the relative benefits for fibromyalgia patients/patient types of different self management skills training concepts – as a complement to medical management.

As lead investigator, psychology professor Mark A. Lumley, PhD, (see video clip here) received a five-year, $3.373 million grant from the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases for the study "Pain and Stress Management for Fibromyalgia."

The study's co-investigators are:

David A. Williams, PhD, and Daniel J. Clauw, MD, at the University of Michigan Chronic Pain & Fatigue Research Center, Ann Arbor

• And Howard Schubiner, MD, at St. John Providence Health System’s Mind-Body Medicine Center in Southfield.

The project proposes that FM is a complex condition whose onset and course involve biological as well as psychological factors, including beliefs, emotions and behaviors – and that stressful life experiences, which are especially prevalent in patients with FM, likely contribute to the condition.

The five-year grant will test three competing psychological/behavioral interventions for fibromyalgia:

Patient education. Focuses on helping patients understand their condition.

Cognitive behavior therapy (CBT). The CBT approach focuses on teaching patients skills to manage their pain and decrease their disability.

Techniques include relaxation, distraction, problem solving and cognitive restructuring. Although CBT is the best supported psychological intervention for FM, research suggests that CBT helps only about a third of FM patients and is not as effective for patients who have unresolved stress or emotional issues.

And a novel emotional awareness and exposure therapy. Dr. Lumley and colleagues have developed and pilot-tested “Emotional Exposure Therapy,” which focuses on reducing stress by helping people confront emotions that they usually avoid. This is done through techniques such as expressive writing, mindfulness exercises and assertiveness training.

Dr. Lumley's team brings together experts in all three of the interventions being tested. He has focused on the relationships between stress, emotion regulation and pain for the past 17 years and has developed and tested various methods to help patients reduce stress and pain. "Research has shown that the brain - and the pain that it generates - are greatly influenced by experiences and how people deal with their thoughts and emotions," Dr. Lumley explains.

"Our goal is to test the effects of helping patients understand their condition, cope with pain or resolve stress."

The study will also examine which types of patients respond best to which intervention.

The researchers will take into account factors such as trauma history, emotion regulation abilities, history of depression and degree of tenderness as predictors of which treatment option will have the most successful outcome for which participants.

"Because there are different factors that cause and maintain fibromyalgia, there likely is not a one-size-fits-all therapy," Dr. Lumley observes. "The hope for this study is that we may better understand these differences among patients, so that more treatment options are available and higher success rates are achieved by those who suffer with the disorder."

Recruitment for the study will begin in February 2011.

• Recruitment will be open to all patients with a diagnosis of FM,

• But the researchers are especially interested in those patients diagnosed with FM in the past few years, including those meeting the new clinical FM diagnostic criteria.

For information about participating in the study, contact the project manager at the Detroit/Southfield location at (313) 577-2258 or the Ann Arbor location at (866) 288-0046.

Source: Excerpted with modifications from Wayne State University news release, Nov 5, 2010




Post a Comment

Featured Products From the ProHealth Store
Fibro Freedom™ Guaifenesin FA™ FibroSleep™


Article Comments Post a Comment

WASTING OUR RESEARCH DOLLARS
Posted by: ValB626
Nov 12, 2010
I can't believe NIH funded this with XMRV and variants implicated in FM as well as ME/CFS! So much for the new SEP at NIH...
Reply Reply

 
NIAMS vs. ME/CFS SEP
Posted by: mezombie
Nov 13, 2010
Review by a SEP is only the first step in grant approval, so I doubt the most recent SEP had anything to do with this.

In addition, researchers don't have to go through the SEP. They can ask for an NIH Institute or Center to review their proposal. That's what may have happened here. The researchers may have gone directly through th NIAMS, the National Institute for Arthritis and M...

I'm not saying this isn't a collosal waste of money. I just want to point out that the latest SEP panel really is good news.

 

 
Optimized Curcumin Longvida with Omega-3

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Fibro Freedom™ Fibro Freedom™
Soothes, Strengthens & Revitalizes
Guaifenesin FA™ Guaifenesin FA™
Helps the Body Eliminate Excess Calcium and Phosphates
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 Your Brain Needs for Detox & Sharpness

Natural Remedies

Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
The Genetic Mutation That May Compromise Your Health - And What to Do About It The Genetic Mutation That May Compromise Your Health - And What to Do About It
Improve Cardiovascular and Metabolic Health with Omega-7 Improve Cardiovascular and Metabolic Health with Omega-7
Break Free From Fibromyalgia Break Free From Fibromyalgia
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map